The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results
- 31 March 1997
- journal article
- Published by Elsevier BV in Urology
- Vol. 49 (3), 46-55
- https://doi.org/10.1016/s0090-4295(97)00169-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerJAMA, 1994
- Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamideUrology, 1992
- Prostate Specific Antigen Levels After Radical Prostatectomy in Patients with Organ Confined and Locally Extensive Prostate CancerJournal of Urology, 1992
- Cancer Control following Anatomical Radical Prostatectomy: An Interim ReportJournal of Urology, 1991
- Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on Normal Prostate and Prostatic AdenocarcinomaThe American Journal of Surgical Pathology, 1991
- Radical Prostatectomy for Clinical Stage T1-2N0M0 Prostatic Adenocarcinoma: Long-Term ResultsJournal of Urology, 1990
- Total Prostatectomy for Localized Prostatic CancerJournal of Urology, 1984
- Review: Prostate cancer epidemiologyThe Prostate, 1984